国际简称:AUST PRESCR 参考译名:澳大利亚处方医师
主要研究方向:MEDICINE, GENERAL & INTERNAL-PHARMACOLOGY & PHARMACY 非预警期刊 审稿周期:>12周,或约稿
《澳大利亚处方医师》(Australian Prescriber)是一本由National Prescribing Service出版的以MEDICINE, GENERAL & INTERNAL-PHARMACOLOGY & PHARMACY为研究特色的国际期刊,发表该领域相关的原创研究文章、评论文章和综述文章,及时报道该领域相关理论、实践和应用学科的最新发现,旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊,近三年没有被列入预警名单。该期刊享有很高的科学声誉,影响因子不断增加,发行量也同样高。
Australian Prescriber is a journal for healthcare professionals whose primary purpose is to provide independent, reliable and easily accessible information to help doctors, pharmacists and other healthcare workers make informed decisions when prescribing. This journal is recognized by the medical community as an authoritative resource, known for its high-quality content and deep insights into clinical practice. The emphasis on the independence of information, which means that the content provided is not influenced by pharmaceutical companies, ensures the objectivity and impartiality of the information. This is critical for medical professionals as it helps them make treatment choices based on the best evidence, rather than commercial interests.
The content of the journal usually includes the latest research results of drugs, guidelines for drug use, treatment guidelines, drug safety information, and drug interactions. Through this content, healthcare professionals are able to obtain the latest knowledge about drug use, including the launch of new drugs, new uses of existing drugs, and the applicability of drugs in specific patient populations.
| CiteScore | SJR | SNIP | CiteScore 指数 | ||||||||
| 4.3 | 0.687 | 1.032 |
|
名词解释:CiteScore 是衡量期刊所发表文献的平均受引用次数,是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年(含计算年度)的被引次数除以该期刊近四年发表的文献数。例如,2022年的 CiteScore 计算方法为:2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量 注:文献类型包括:文章、评论、会议论文、书籍章节和数据论文。
| Top期刊 | 综述期刊 | 大类学科 | 小类学科 | ||
| 否 | 否 | 医学 | 2区 | PHARMACOLOGY & PHARMACY 药学 | 2区 |
| 按JCI指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
| 学科:PHARMACOLOGY & PHARMACY | ESCI | Q2 | 95 / 356 |
73.5 |
| 学科:PHARMACOLOGY & PHARMACY | ESCI | Q2 | 92 / 356 |
74.3 |
Frontiers In Public Health
中科院 3区 JCR Q1
Frontiers In Pharmacology
中科院 2区 JCR Q1
Biomedicine & Pharmacotherapy
中科院 2区 JCR Q1
Discover Oncology
中科院 3区 JCR Q3
Medcomm
中科院 1区 JCR Q1
Bmc Psychiatry
中科院 2区 JCR Q1
Bmc Neurology
中科院 3区 JCR Q3
Public Health Nursing
中科院 4区 JCR Q3
若用户需要出版服务,请联系出版商:NATIONAL PRESCRIBING SERVICE LTD, SUITE 3, 2 PHIPPS CLOSE, DEAKIN, AUSTRALIA, ACT 2600。